Trial Outcomes & Findings for LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert Study (NCT NCT00510458)

NCT ID: NCT00510458

Last Updated: 2018-03-12

Results Overview

Linear wear rate is defined as the annual rate of removal of the polyethylene from the X3 polyethylene insert mated with LFIT™ Anatomic CoCr Femoral Heads determined by comparing digitized images of serial radiographs obtained over the follow-up period. .

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

89 participants

Primary outcome timeframe

5 Years Post-Surgery

Results posted on

2018-03-12

Participant Flow

89 patients/96 hips - 15 patients/18 hips censored = 74 patients/78 hips

Unit of analysis: hips

Participant milestones

Participant milestones
Measure
LFIT™Femoral Heads With X3® Insert
LFIT™ Femoral Heads With X3® Insert: LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert in total hip replacement
Overall Study
STARTED
74 78
Overall Study
COMPLETED
27 27
Overall Study
NOT COMPLETED
47 51

Reasons for withdrawal

Reasons for withdrawal
Measure
LFIT™Femoral Heads With X3® Insert
LFIT™ Femoral Heads With X3® Insert: LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert in total hip replacement
Overall Study
5 year not evaluable/missed
21
Overall Study
Death
1
Overall Study
Terminated
14
Overall Study
Lost to Follow-up
6
Overall Study
Withdrawal by Subject
3
Overall Study
Revision
2

Baseline Characteristics

LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert Study

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
LFIT™Femoral Heads With X3® Insert
n=74 Participants
LFIT™ Femoral Heads With X3® Insert: LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert in total hip replacement
Age, Continuous
61.48 years
STANDARD_DEVIATION 10.37 • n=99 Participants
Sex: Female, Male
Female
27 Participants
n=99 Participants
Sex: Female, Male
Male
47 Participants
n=99 Participants
Region of Enrollment
United States
74 Participants
n=99 Participants

PRIMARY outcome

Timeframe: 5 Years Post-Surgery

Population: Participants/hips with available data.

Linear wear rate is defined as the annual rate of removal of the polyethylene from the X3 polyethylene insert mated with LFIT™ Anatomic CoCr Femoral Heads determined by comparing digitized images of serial radiographs obtained over the follow-up period. .

Outcome measures

Outcome measures
Measure
LFIT™Femoral Heads With X3® Insert
n=27 hips
LFIT™ Femoral Heads With X3® Insert: LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert in total hip replacement
Linear Wear Rate
0.008 mm/year
Standard Deviation 0.057

SECONDARY outcome

Timeframe: preoperative, 1, 3, and 5 years

Population: Participants/hips with available data. Overall number of participants and hips analyzed is based upon the preoperative population.

The change in HHS is reported by comparing the mean preoperative, 1, 3, and 5 year scores. The HHS assesses pain, function, joint deformity and range of motion. Scores can range from 0 to 100 with 0 being the worst and 100 being the best score. A score of 80-100 is considered good-excellent and a score of less than or equal to 79 is considered fair-poor. 90-100 = excellent 80-89 = good 70-79 = fair 0-69 = poor

Outcome measures

Outcome measures
Measure
LFIT™Femoral Heads With X3® Insert
n=77 hips
LFIT™ Femoral Heads With X3® Insert: LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert in total hip replacement
Change in Harris Hip Score (HHS) From Pre-operative to Post-operative Visits
Mean HHS score preoperative
51.03 units on a scale
Standard Deviation 11.25
Change in Harris Hip Score (HHS) From Pre-operative to Post-operative Visits
Mean HHS 1 year
94.14 units on a scale
Standard Deviation 9.45
Change in Harris Hip Score (HHS) From Pre-operative to Post-operative Visits
Mean HHS 3 years
97.98 units on a scale
Standard Deviation 4.51
Change in Harris Hip Score (HHS) From Pre-operative to Post-operative Visits
Mean HHS 5 years
97.59 units on a scale
Standard Deviation 6.07

SECONDARY outcome

Timeframe: preop, 1, 3, and 5 Years

Population: Participants/hips with available data. Overall number of participants and hips analyzed is based upon the preoperative population.

This subscore of the overall HHS provides the patient with 6 possible answers to choose from ranging from, no pain/ignores it, to totally disabled/crippled/pain in bed/bedridden. A maximum of 44 points is possible for this subscore indicating no pain/ignores it. Pain: 1. None or ignores it = 44 points 2. Slight, occasional, no compromise in activities = 40 points 3. Mild pain, no effect on average activities, rarely moderate pain with unusual activity, may take aspirin = 30 points 4. Moderate pain, tolerable but makes concessions to pain. Some limitation of ordinary activity or work. May require occasional pain medicine stronger than aspirin = 20 points 5. Marked pain, serious limitation of activities = 10 points 6. Totally disabled, crippled, pain in bed, bedridden = 0 points

Outcome measures

Outcome measures
Measure
LFIT™Femoral Heads With X3® Insert
n=78 hips
LFIT™ Femoral Heads With X3® Insert: LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert in total hip replacement
Change in Harris Hip Score (HHS) Pain Score From Pre-operative to Post-operative Visits
Mean HHS Pain score preoperative
15.77 units on a scale
Standard Deviation 5.23
Change in Harris Hip Score (HHS) Pain Score From Pre-operative to Post-operative Visits
Mean HHS Pain score 1 year
41.36 units on a scale
Standard Deviation 5.14
Change in Harris Hip Score (HHS) Pain Score From Pre-operative to Post-operative Visits
Mean HHS Pain score 3 years
43.39 units on a scale
Standard Deviation 2.24
Change in Harris Hip Score (HHS) Pain Score From Pre-operative to Post-operative Visits
Mean HHS Pain score 5 years
42.89 units on a scale
Standard Deviation 4.48

SECONDARY outcome

Timeframe: preoperative, 1, 3, and 5 Years

Population: Participants/hips with available data. Overall number of participants and hips analyzed is based upon the preoperative population. Cases at 1 and 5 years all had a score of 5, therefore there is zero standard deviation.

This subscore of the overall HHS includes the total points awarded for five different ranges of motion (flexion, abduction, external rotation, internal rotation, adduction). Subscore range is minimum of 0 to maximum of 5 points; the higher the value, the better the outcome. Flexion: 0-45 degrees x 1.0 index value = max 45 points 45-90 degrees x 0.6 index = max 27 points 90-110 degrees x 0.3 index = max 6 points 110-130 degrees = max 0 points Abduction: 0-15 degrees x 0.8 index = max 12 points 15-20 degrees x 0.3 index = max 1.5 points 20-45 degrees x 0 index = max 0 points External Rotation in extension: 0-15 degrees x 0.4 index = max 6 points Over 15 degrees = max 0 points Internal Rotation in extension: Any = max 0 points Adduction: 0-15 degrees x 0.2 index = max 3 points Over 15 degrees - max 0 points To determine the over-all rating for range of motion, multiply the sum of the index values x 0.05.

Outcome measures

Outcome measures
Measure
LFIT™Femoral Heads With X3® Insert
n=78 hip
LFIT™ Femoral Heads With X3® Insert: LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert in total hip replacement
Change in Harris Hip Score (HHS) Range of Motion (ROM) Score From Pre-operative to Post-operative Visits.
HHS ROM preoperative
4.05 units on a scale
Standard Deviation 0.82
Change in Harris Hip Score (HHS) Range of Motion (ROM) Score From Pre-operative to Post-operative Visits.
HHS ROM 1 year
5.00 units on a scale
Standard Deviation 0
Change in Harris Hip Score (HHS) Range of Motion (ROM) Score From Pre-operative to Post-operative Visits.
HHS ROM 3 years
4.98 units on a scale
Standard Deviation 0.14
Change in Harris Hip Score (HHS) Range of Motion (ROM) Score From Pre-operative to Post-operative Visits.
HHS ROM 5 years
5.00 units on a scale
Standard Deviation 0

SECONDARY outcome

Timeframe: preop, 1, 3, and 5 Years

Population: Participants/hips with available data. Overall number of participants and hips analyzed is based upon the preoperative population.

The change in SF-12 is reported by comparing the mean preoperative, 1, 3, and 5 year scores. The SF-12 Health Survey is a 12 item patient completed questionnaire to measure general health and well-being. It includes a physical component score and mental status component score; each ranging from 0-100. Low values represent a poor health state and high values represent a good health state.

Outcome measures

Outcome measures
Measure
LFIT™Femoral Heads With X3® Insert
n=73 hips
LFIT™ Femoral Heads With X3® Insert: LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert in total hip replacement
Change in SF-12 Health Survey Score (Physical and Mental) From Pre-operative to Post-operative Intervals.
SF-12 physical component score preoperative
34.8 units on a scale
Standard Deviation 9.47
Change in SF-12 Health Survey Score (Physical and Mental) From Pre-operative to Post-operative Intervals.
SF-12 physical component score 1 year
49.93 units on a scale
Standard Deviation 9.39
Change in SF-12 Health Survey Score (Physical and Mental) From Pre-operative to Post-operative Intervals.
SF-12 physical component score 3 years
52.51 units on a scale
Standard Deviation 7
Change in SF-12 Health Survey Score (Physical and Mental) From Pre-operative to Post-operative Intervals.
SF-12 physical component score 5 years
50.35 units on a scale
Standard Deviation 9.89
Change in SF-12 Health Survey Score (Physical and Mental) From Pre-operative to Post-operative Intervals.
SF-12 mental component score preoperative
50.75 units on a scale
Standard Deviation 12.56
Change in SF-12 Health Survey Score (Physical and Mental) From Pre-operative to Post-operative Intervals.
SF-12 mental component score 1 year
55.63 units on a scale
Standard Deviation 7.47
Change in SF-12 Health Survey Score (Physical and Mental) From Pre-operative to Post-operative Intervals.
SF-12 mental component score 3 years
55.25 units on a scale
Standard Deviation 8.91
Change in SF-12 Health Survey Score (Physical and Mental) From Pre-operative to Post-operative Intervals.
SF-12 mental component score 5 years
55.92 units on a scale
Standard Deviation 6.71

SECONDARY outcome

Timeframe: preoperative, 1, 3, and 5 Years

Population: Participants/hips with available data. Overall number of participants and hips analyzed is based upon the preoperative population.

The change in LEAS is reported by comparing the mean pre-operative, 1,3,and 5 year scores. The LEAS completed by the participant to assess activity level. Activity levels were ordered in terms of intensity from 1 to 18, with 18 indicating the highest activity level.

Outcome measures

Outcome measures
Measure
LFIT™Femoral Heads With X3® Insert
n=78 hips
LFIT™ Femoral Heads With X3® Insert: LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert in total hip replacement
Change in Lower Extremity Activity Scale (LEAS) From Pre-operative to Post-operative
LEAS 3 years
12.56 units on a scale
Standard Deviation 3.11
Change in Lower Extremity Activity Scale (LEAS) From Pre-operative to Post-operative
LEAS Preoperative
9.41 units on a scale
Standard Deviation 2.93
Change in Lower Extremity Activity Scale (LEAS) From Pre-operative to Post-operative
LEAS 1 year
11.76 units on a scale
Standard Deviation 3.05
Change in Lower Extremity Activity Scale (LEAS) From Pre-operative to Post-operative
LEAS 5 years
12.33 units on a scale
Standard Deviation 2.69

SECONDARY outcome

Timeframe: 3 and 5 years

Population: Participants/hips with available data. Overall number of participants and hips analyzed is based upon the 3 year population.

The number of hips that experienced a hip dislocation.

Outcome measures

Outcome measures
Measure
LFIT™Femoral Heads With X3® Insert
n=47 hips
LFIT™ Femoral Heads With X3® Insert: LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert in total hip replacement
Number of Hips That Dislocated
Hip dislocations 3 years
0 hips
Number of Hips That Dislocated
Hip dislocations 5 years
0 hips

SECONDARY outcome

Timeframe: 1, 3, 5 years

Population: Participants/hips with available data. Overall number of participants and hips analyzed is based upon the 1 year population.

Radiographic instability is defined as having any of the following findings on x-ray: * Radiographic indication of progressive radiolucent lines ≥ 2 mm in thickness around the entire acetabular component * Radiographic indication of migration of ≥ 3 mm or ≥ 5° of the acetabular component * Radiographic indication of progressive radiolucent lines ≥ 2 mm thickness around the entire femoral component * Radiographic indication of progressive subsidence of the femoral component of ≥ 5 mm.

Outcome measures

Outcome measures
Measure
LFIT™Femoral Heads With X3® Insert
n=58 hips
LFIT™ Femoral Heads With X3® Insert: LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert in total hip replacement
Number of Hips Evaluated as Radiographically Unstable
Radiographically Unstable Hips 1 year
0 hips
Number of Hips Evaluated as Radiographically Unstable
Radiographically Unstable Hips 3 years
0 hips
Number of Hips Evaluated as Radiographically Unstable
Radiographically Unstable Hips 5 years
0 hips

SECONDARY outcome

Timeframe: 5 years

Population: Participants/hips with available data.

A revision is defined as surgical removal and replacement of the femoral bearing head or femoral stem components, or the acetabular shell or acetabular polyethylene liner. The 97.42% estimate is obtained by Kaplan-Meier method.

Outcome measures

Outcome measures
Measure
LFIT™Femoral Heads With X3® Insert
n=78 hips
LFIT™ Femoral Heads With X3® Insert: LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert in total hip replacement
Percentage of Cases That Did Not Have Any Component Revised
97.42 percentage of hips

Adverse Events

Operative Site Events

Serious events: 2 serious events
Other events: 20 other events
Deaths: 0 deaths

Non-operative Site Events

Serious events: 2 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Operative Site Events
n=78 participants at risk
LFIT™ Femoral Heads With X3® Insert. Operative site events are reported by hip because in the case of bilateral participants (this is when one participant has both hips enrolled in the study), an event can occur in one hip, both hips or the same hip at different times and are counted separately for this reason.
Non-operative Site Events
n=74 participants at risk
LFIT™ Femoral Heads With X3® Insert. Non-operative site events are reported by participant.
Infections and infestations
Operative Site
1.3%
1/78 • Number of events 1 • Adverse event data was collected to the 5 year postoperative interval. Reportable AEs for this study include those that are serious or related to surgery and/or to the operative site.
Censored protocol deviations were not included as risk participants. Industry standard AE terms not used;specific AE terms not used for all AEs. Elective procedures not included, e.g. non-study joint replacement/revision,rotator cuff repair,carpal tunnel release,cataract,intra-ocular and bunion procedures,total shoulder repair,laminectomy, microdiscectomy,breast reduction, cervical spine fusion, mid-foot/flat-foot surgery.
0/0 • Adverse event data was collected to the 5 year postoperative interval. Reportable AEs for this study include those that are serious or related to surgery and/or to the operative site.
Censored protocol deviations were not included as risk participants. Industry standard AE terms not used;specific AE terms not used for all AEs. Elective procedures not included, e.g. non-study joint replacement/revision,rotator cuff repair,carpal tunnel release,cataract,intra-ocular and bunion procedures,total shoulder repair,laminectomy, microdiscectomy,breast reduction, cervical spine fusion, mid-foot/flat-foot surgery.
Musculoskeletal and connective tissue disorders
Operative Site
1.3%
1/78 • Number of events 1 • Adverse event data was collected to the 5 year postoperative interval. Reportable AEs for this study include those that are serious or related to surgery and/or to the operative site.
Censored protocol deviations were not included as risk participants. Industry standard AE terms not used;specific AE terms not used for all AEs. Elective procedures not included, e.g. non-study joint replacement/revision,rotator cuff repair,carpal tunnel release,cataract,intra-ocular and bunion procedures,total shoulder repair,laminectomy, microdiscectomy,breast reduction, cervical spine fusion, mid-foot/flat-foot surgery.
1.4%
1/74 • Number of events 1 • Adverse event data was collected to the 5 year postoperative interval. Reportable AEs for this study include those that are serious or related to surgery and/or to the operative site.
Censored protocol deviations were not included as risk participants. Industry standard AE terms not used;specific AE terms not used for all AEs. Elective procedures not included, e.g. non-study joint replacement/revision,rotator cuff repair,carpal tunnel release,cataract,intra-ocular and bunion procedures,total shoulder repair,laminectomy, microdiscectomy,breast reduction, cervical spine fusion, mid-foot/flat-foot surgery.
General disorders
Non-Operative
0/0 • Adverse event data was collected to the 5 year postoperative interval. Reportable AEs for this study include those that are serious or related to surgery and/or to the operative site.
Censored protocol deviations were not included as risk participants. Industry standard AE terms not used;specific AE terms not used for all AEs. Elective procedures not included, e.g. non-study joint replacement/revision,rotator cuff repair,carpal tunnel release,cataract,intra-ocular and bunion procedures,total shoulder repair,laminectomy, microdiscectomy,breast reduction, cervical spine fusion, mid-foot/flat-foot surgery.
1.4%
1/74 • Number of events 1 • Adverse event data was collected to the 5 year postoperative interval. Reportable AEs for this study include those that are serious or related to surgery and/or to the operative site.
Censored protocol deviations were not included as risk participants. Industry standard AE terms not used;specific AE terms not used for all AEs. Elective procedures not included, e.g. non-study joint replacement/revision,rotator cuff repair,carpal tunnel release,cataract,intra-ocular and bunion procedures,total shoulder repair,laminectomy, microdiscectomy,breast reduction, cervical spine fusion, mid-foot/flat-foot surgery.

Other adverse events

Other adverse events
Measure
Operative Site Events
n=78 participants at risk
LFIT™ Femoral Heads With X3® Insert. Operative site events are reported by hip because in the case of bilateral participants (this is when one participant has both hips enrolled in the study), an event can occur in one hip, both hips or the same hip at different times and are counted separately for this reason.
Non-operative Site Events
n=74 participants at risk
LFIT™ Femoral Heads With X3® Insert. Non-operative site events are reported by participant.
Musculoskeletal and connective tissue disorders
Operative Site
25.6%
20/78 • Number of events 24 • Adverse event data was collected to the 5 year postoperative interval. Reportable AEs for this study include those that are serious or related to surgery and/or to the operative site.
Censored protocol deviations were not included as risk participants. Industry standard AE terms not used;specific AE terms not used for all AEs. Elective procedures not included, e.g. non-study joint replacement/revision,rotator cuff repair,carpal tunnel release,cataract,intra-ocular and bunion procedures,total shoulder repair,laminectomy, microdiscectomy,breast reduction, cervical spine fusion, mid-foot/flat-foot surgery.
0/0 • Adverse event data was collected to the 5 year postoperative interval. Reportable AEs for this study include those that are serious or related to surgery and/or to the operative site.
Censored protocol deviations were not included as risk participants. Industry standard AE terms not used;specific AE terms not used for all AEs. Elective procedures not included, e.g. non-study joint replacement/revision,rotator cuff repair,carpal tunnel release,cataract,intra-ocular and bunion procedures,total shoulder repair,laminectomy, microdiscectomy,breast reduction, cervical spine fusion, mid-foot/flat-foot surgery.

Additional Information

Director, Clinical Operations

Stryker Orthopaedics

Phone: 201-831-5401

Results disclosure agreements

  • Principal investigator is a sponsor employee Each investigator shall have privileges for their own center's results at the completion of the study.These manuscripts and abstracts will be delayed until after the multi-center publication is submitted. All publications shall be submitted to the sponsor for review at least 60 days prior to submission for publication. Stryker's review ensures no disclosure of confidential info, no promotion of off-label use, and data is accurate.
  • Publication restrictions are in place

Restriction type: OTHER